Vermeire S, Colombel JF, Danese S, Panaccione R, et al. Benefit-Risk Profile of Upadacitinib: Exploratory Post Hoc Analysis of Phase 2b/3 Studies in Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease. J Crohns Colitis 2025 Nov 20:jjaf198. doi: 10.1093.
PMID: 41264726